Company Filing History:
Years Active: 2001-2003
Title: Innovations of Ernese Csuzdi
Introduction
Ernese Csuzdi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target AMPA receptors. With a total of two patents to his name, his work is recognized for its potential impact on treating central nervous system diseases.
Latest Patents
Csuzdi's latest patents include the invention of condensed 2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors. These compounds, described by the formula I, are produced and utilized in pharmaceutical agents. The invention details that the compounds can have various substituents, including hydrogen or halogen, and can form a five-member heterocycle with nitrogen and oxygen atoms. Due to their non-competitive inhibition of AMPA receptors, these compounds hold promise as medicaments for treating diseases affecting the central nervous system.
Career Highlights
Ernese Csuzdi is currently associated with Schering Aktiengesellschaft, a company known for its focus on pharmaceutical innovations. His work has contributed to advancements in drug development, particularly in the area of neurological treatments.
Collaborations
Csuzdi has collaborated with notable colleagues, including Antal Simay and Eszter Szentkuti. Their combined expertise has likely enhanced the research and development processes within their projects.
Conclusion
Ernese Csuzdi's contributions to pharmaceutical innovations, particularly through his patents on AMPA-receptor inhibitors, highlight his role as a significant inventor in the field. His work continues to pave the way for potential treatments for central nervous system diseases.